AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

AIDSinfo Releases New Edition of HIV/AIDS Glossary Featuring the Addition of Images

viral_load_art

AIDSinfo, a service of the U.S. Department of Health and Human Services, offers access to many Federal HIV-related resources, including the AIDSinfo Glossary of HIV/AIDS-Related Terms, a guide to help people understand the complex terminology of HIV/AIDS. The glossary includes definitions in English and Spanish for more than 700 HIV/AIDS-related terms. The latest edition of…

Be a Part of the NIH Digital Summit on October 19th

nih_digital_summit

Have you heard? You can join the National Institutes of Health (NIH) Digital Summit on October 19th. The free, day-long event will highlight “how digital is being used by government agencies, clinicians, [caregivers], scientists, patients, and the public to communicate information on health and science.”   Digital tools and technology are changing rapidly. At AIDS.gov, we…

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic

NIH logo

Extraordinary progress has been made in HIV/AIDS research over the last 34 years, transforming what was once a terrifying and almost inevitably fatal disease into a treatable disorder. People with HIV/AIDS can now experience an almost normal life expectancy if antiretrovirals are started promptly and continued for life. But the disease remains a significant public…

HIV Vaccine and Cure Research Highlights from IAS 2015

"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
Vancouver, Canada.
Copyright: Marcus Rose/IAS
Image Shows: (WEPL01) Co-chair: Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa, South Africa"

As the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) came to a close in Vancouver, Canada, we spoke one last time by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of the…

PrEP and Additional Benefits of HIV Treatment Among Science Highlights from IAS 2015

"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
Vancouver, Canada.
Copyright: Marcus Rose/IAS
Image Shows: (WEPL01) Co-chair: Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa, South Africa"

More HIV research findings were shared yesterday as the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) continued in Vancouver, Canada. We spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of…

CDC and NIH Share PrEP Research at IAS 2015

IAS2015 logo crop2

New findings on pre-exposure prophylaxis (PrEP) from both CDC and NIH were among the HIV research findings shared on July 21 at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) in Vancouver, Canada.  Below are highlights of some of the information they have shared. CDC Study Finds High Adherence…

NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins

IAS2015 logo crop2

After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July 20, we spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared some highlights from the first full…

The Importance of Integrating HIV and Addiction Treatment

NIDA logo

Great progress has been made in reducing the number of new HIV infections and transforming the disease into a manageable and livable condition, but we still have some way to go to achieve an AIDS-free world. Injection drug use is still creating new, local epidemics, and the ways substance use disorders and HIV are intertwined…